Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors

The Motley Fool · Jake Lerch · 2026-11-07 16:15 UTC

IHE offers lower costs and higher income through a concentrated play on established drugmakers, while IBB provides broader exposure to 243 biotech firms with higher volatility.

Read the full story at The Motley Fool · All coverage of this story